Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane transporter binding	AKAP6 STX1A CTNNB1 SLC5A3	2.01e-04	172	34	4	GO:0044325
GeneOntologyBiologicalProcess	regulation of nucleus organization	NFE2L1 SYNE1	2.48e-06	2	33	2	GO:1903353
GeneOntologyBiologicalProcess	cellular response to organic cyclic compound	AKAP6 SAFB2 PRKD1 TAF1 CTNNB1 DTNBP1 NFE2L1 RYR2	3.80e-06	605	33	8	GO:0071407
GeneOntologyBiologicalProcess	protein polyubiquitination	DCAF15 TAF1 CTNNB1 SASH1 NFE2L1 CDC16	5.79e-06	289	33	6	GO:0000209
GeneOntologyBiologicalProcess	endomembrane system organization	PRKD1 EMC7 STX1A DTNBP1 CHMP2A SYNE1 NBEAL2 CHMP2B	8.21e-06	672	33	8	GO:0010256
GeneOntologyBiologicalProcess	regulation of protein autoubiquitination	TAF1 SASH1	3.71e-05	6	33	2	GO:1902498
GeneOntologyBiologicalProcess	protein modification by small protein conjugation	DCAF15 STX1A TAF1 CTNNB1 SASH1 NFE2L1 KLHL18 CDC16	6.32e-05	893	33	8	GO:0032446
GeneOntologyBiologicalProcess	ESCRT III complex disassembly	CHMP2A CHMP2B	1.11e-04	10	33	2	GO:1904903
GeneOntologyBiologicalProcess	ESCRT complex disassembly	CHMP2A CHMP2B	1.11e-04	10	33	2	GO:1904896
GeneOntologyBiologicalProcess	regulation of odontoblast differentiation	CTNNB1 NFE2L1	1.35e-04	11	33	2	GO:1901329
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	DCAF15 STX1A TAF1 CTNNB1 SASH1 NFE2L1 KLHL18 CDC16	1.48e-04	1009	33	8	GO:0070647
GeneOntologyBiologicalProcess	nucleus organization	CHMP2A NFE2L1 SYNE1 CHMP2B	1.51e-04	170	33	4	GO:0006997
GeneOntologyBiologicalProcess	vesicle fusion with vacuole	CHMP2A CHMP2B	1.91e-04	13	33	2	GO:0051469
GeneOntologyBiologicalProcess	multivesicular body-lysosome fusion	CHMP2A CHMP2B	1.91e-04	13	33	2	GO:0061763
GeneOntologyBiologicalProcess	response to organic cyclic compound	AKAP6 SAFB2 PRKD1 TAF1 CTNNB1 DTNBP1 NFE2L1 RYR2	1.93e-04	1048	33	8	GO:0014070
GeneOntologyBiologicalProcess	vacuole fusion	CHMP2A CHMP2B	2.23e-04	14	33	2	GO:0097576
GeneOntologyBiologicalProcess	viral budding from plasma membrane	CHMP2A CHMP2B	2.23e-04	14	33	2	GO:0046761
GeneOntologyBiologicalProcess	cellular response to epinephrine stimulus	AKAP6 RYR2	2.23e-04	14	33	2	GO:0071872
GeneOntologyBiologicalProcess	post-translational protein modification	DCAF15 STX1A TAF1 CTNNB1 SASH1 NFE2L1 KLHL18 CDC16	2.28e-04	1074	33	8	GO:0043687
GeneOntologyBiologicalProcess	positive regulation of transport	AKAP6 NADK PRKD1 STX1A DTNBP1 CHMP2A SYNE1 RYR2	2.38e-04	1081	33	8	GO:0051050
GeneOntologyBiologicalProcess	protein ubiquitination	DCAF15 TAF1 CTNNB1 SASH1 NFE2L1 KLHL18 CDC16	2.47e-04	811	33	7	GO:0016567
GeneOntologyBiologicalProcess	non-lytic viral release	CHMP2A CHMP2B	2.57e-04	15	33	2	GO:0046753
GeneOntologyBiologicalProcess	regulation of cell cycle process	TAF1 CTNNB1 CHMP2A NFE2L1 KLHL18 CDC16 CHMP2B	3.17e-04	845	33	7	GO:0010564
GeneOntologyBiologicalProcess	response to epinephrine	AKAP6 RYR2	3.33e-04	17	33	2	GO:0071871
GeneOntologyBiologicalProcess	lysosomal membrane organization	CHMP2A CHMP2B	3.74e-04	18	33	2	GO:0097212
GeneOntologyBiologicalProcess	endosome to lysosome transport via multivesicular body sorting pathway	CHMP2A CHMP2B	4.17e-04	19	33	2	GO:0032510
GeneOntologyBiologicalProcess	glial cell fate commitment	CTNNB1 NFE2L1	4.17e-04	19	33	2	GO:0021781
GeneOntologyBiologicalProcess	midbody abscission	CHMP2A CHMP2B	4.17e-04	19	33	2	GO:0061952
GeneOntologyBiologicalProcess	odontoblast differentiation	CTNNB1 NFE2L1	4.17e-04	19	33	2	GO:0071895
GeneOntologyBiologicalProcess	positive regulation of secretion by cell	NADK PRKD1 STX1A DTNBP1 CHMP2A	4.25e-04	404	33	5	GO:1903532
GeneOntologyBiologicalProcess	vesicle organization	STX1A DTNBP1 CHMP2A NBEAL2 CHMP2B	4.80e-04	415	33	5	GO:0016050
GeneOntologyBiologicalProcess	regulation of release of sequestered calcium ion into cytosol	AKAP6 PRKD1 RYR2	5.12e-04	98	33	3	GO:0051279
GeneOntologyBiologicalProcess	positive regulation of secretion	NADK PRKD1 STX1A DTNBP1 CHMP2A	5.95e-04	435	33	5	GO:0051047
GeneOntologyBiologicalProcess	late endosome to lysosome transport	CHMP2A CHMP2B	6.15e-04	23	33	2	GO:1902774
GeneOntologyBiologicalProcess	viral budding via host ESCRT complex	CHMP2A CHMP2B	6.15e-04	23	33	2	GO:0039702
GeneOntologyBiologicalProcess	regulation of mitotic spindle assembly	CHMP2A CHMP2B	6.70e-04	24	33	2	GO:1901673
GeneOntologyBiologicalProcess	positive regulation of neurotransmitter secretion	STX1A DTNBP1	7.28e-04	25	33	2	GO:0001956
GeneOntologyBiologicalProcess	regulation of striated muscle contraction	AKAP6 PRKD1 RYR2	7.36e-04	111	33	3	GO:0006942
GeneOntologyBiologicalProcess	maintenance of location in cell	AKAP6 PRKD1 SYNE1 RYR2	7.46e-04	259	33	4	GO:0051651
GeneOntologyBiologicalProcess	organelle localization	STX1A CTNNB1 DTNBP1 CHMP2A SYNE1 CHMP2B	7.74e-04	703	33	6	GO:0051640
GeneOntologyBiologicalProcess	viral budding	CHMP2A CHMP2B	7.88e-04	26	33	2	GO:0046755
GeneOntologyBiologicalProcess	nuclear membrane reassembly	CHMP2A CHMP2B	7.88e-04	26	33	2	GO:0031468
GeneOntologyBiologicalProcess	response to muscle stretch	CTNNB1 RYR2	9.14e-04	28	33	2	GO:0035994
GeneOntologyBiologicalProcess	regulation of organelle assembly	EVI5 CHMP2A SYNE1 CHMP2B	9.98e-04	280	33	4	GO:1902115
GeneOntologyBiologicalProcess	regulation of organelle organization	EVI5 PRKD1 CTNNB1 CHMP2A NFE2L1 SYNE1 CDC16 CHMP2B	1.01e-03	1342	33	8	GO:0033043
GeneOntologyBiologicalProcess	viral release from host cell	CHMP2A CHMP2B	1.05e-03	30	33	2	GO:0019076
GeneOntologyBiologicalProcess	exit from host cell	CHMP2A CHMP2B	1.05e-03	30	33	2	GO:0035891
GeneOntologyBiologicalProcess	cellular response to nitrogen compound	AKAP6 PRKD1 TAF1 CTNNB1 DTNBP1 RYR2	1.10e-03	752	33	6	GO:1901699
GeneOntologyBiologicalProcess	cellular response to alcohol	PRKD1 CTNNB1 NFE2L1	1.16e-03	130	33	3	GO:0097306
GeneOntologyBiologicalProcess	positive regulation of neurotransmitter transport	STX1A DTNBP1	1.19e-03	32	33	2	GO:0051590
GeneOntologyBiologicalProcess	mitotic cytokinetic process	CHMP2A CHMP2B	1.27e-03	33	33	2	GO:1902410
GeneOntologyBiologicalProcess	multivesicular body assembly	CHMP2A CHMP2B	1.27e-03	33	33	2	GO:0036258
GeneOntologyBiologicalProcess	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	AKAP6 RYR2	1.27e-03	33	33	2	GO:0010880
GeneOntologyBiologicalProcess	plasma membrane repair	CHMP2A CHMP2B	1.35e-03	34	33	2	GO:0001778
GeneOntologyBiologicalProcess	multivesicular body organization	CHMP2A CHMP2B	1.35e-03	34	33	2	GO:0036257
GeneOntologyBiologicalProcess	regulation of spindle assembly	CHMP2A CHMP2B	1.35e-03	34	33	2	GO:0090169
GeneOntologyBiologicalProcess	virion assembly	CHMP2A CHMP2B	1.43e-03	35	33	2	GO:0019068
GeneOntologyBiologicalProcess	vesicle fusion	STX1A CHMP2A CHMP2B	1.50e-03	142	33	3	GO:0006906
GeneOntologyBiologicalProcess	positive regulation of mesenchymal cell proliferation	CTNNB1 SYNE1	1.51e-03	36	33	2	GO:0002053
GeneOntologyBiologicalProcess	positive regulation of molecular function	AKAP6 EVI5 PRKD1 TAF1 CTNNB1 SASH1 RYR2 SLC5A3	1.52e-03	1430	33	8	GO:0044093
GeneOntologyBiologicalProcess	mitotic nuclear division	CHMP2A NFE2L1 CDC16 CHMP2B	1.56e-03	316	33	4	GO:0140014
GeneOntologyBiologicalProcess	organelle membrane fusion	STX1A CHMP2A CHMP2B	1.56e-03	144	33	3	GO:0090174
GeneOntologyBiologicalProcess	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	CHMP2A CHMP2B	1.60e-03	37	33	2	GO:0043162
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	AKAP6 RYR2	1.60e-03	37	33	2	GO:0014808
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol	AKAP6 PRKD1 RYR2	1.62e-03	146	33	3	GO:0051209
GeneOntologyBiologicalProcess	proteolysis involved in protein catabolic process	TAF1 CTNNB1 CHMP2A NFE2L1 CDC16 CHMP2B	1.63e-03	812	33	6	GO:0051603
GeneOntologyBiologicalProcess	establishment of organelle localization	CTNNB1 DTNBP1 CHMP2A SYNE1 CHMP2B	1.64e-03	546	33	5	GO:0051656
GeneOntologyBiologicalProcess	vesicle-mediated transport in synapse	STX1A CTNNB1 DTNBP1 SYNE1	1.65e-03	321	33	4	GO:0099003
GeneOntologyBiologicalProcess	negative regulation of sequestering of calcium ion	AKAP6 PRKD1 RYR2	1.65e-03	147	33	3	GO:0051283
GeneOntologyBiologicalProcess	cellular response to oxygen-containing compound	AKAP6 NADK PRKD1 TAF1 CTNNB1 DTNBP1 SASH1 NFE2L1	1.66e-03	1450	33	8	GO:1901701
GeneOntologyBiologicalProcess	regulation of calcium ion transport	AKAP6 PRKD1 CTNNB1 RYR2	1.69e-03	323	33	4	GO:0051924
GeneOntologyBiologicalProcess	regulation of sequestering of calcium ion	AKAP6 PRKD1 RYR2	1.72e-03	149	33	3	GO:0051282
GeneOntologyBiologicalProcess	cardiac muscle tissue development	AKAP6 CTNNB1 SYNE1 RYR2	1.77e-03	327	33	4	GO:0048738
GeneOntologyBiologicalProcess	late endosome to vacuole transport	CHMP2A CHMP2B	1.77e-03	39	33	2	GO:0045324
GeneOntologyBiologicalProcess	positive regulation of calcium ion transmembrane transporter activity	AKAP6 RYR2	1.77e-03	39	33	2	GO:1901021
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by endoplasmic reticulum	AKAP6 RYR2	1.77e-03	39	33	2	GO:1903514
GeneOntologyBiologicalProcess	sequestering of calcium ion	AKAP6 PRKD1 RYR2	1.85e-03	153	33	3	GO:0051208
GeneOntologyBiologicalProcess	endosome transport via multivesicular body sorting pathway	CHMP2A CHMP2B	2.15e-03	43	33	2	GO:0032509
GeneOntologyBiologicalProcess	regulation of cardiac muscle cell contraction	AKAP6 RYR2	2.15e-03	43	33	2	GO:0086004
GeneOntologyBiologicalProcess	muscle structure development	AKAP6 PRKD1 CTNNB1 DTNBP1 SYNE1 RYR2	2.15e-03	858	33	6	GO:0061061
GeneOntologyBiologicalProcess	striated muscle tissue development	AKAP6 CTNNB1 SYNE1 RYR2	2.24e-03	349	33	4	GO:0014706
GeneOntologyBiologicalProcess	regulation of mitotic spindle organization	CHMP2A CHMP2B	2.25e-03	44	33	2	GO:0060236
GeneOntologyBiologicalProcess	sarcoplasmic reticulum calcium ion transport	AKAP6 RYR2	2.25e-03	44	33	2	GO:0070296
GeneOntologyBiologicalProcess	centrosome cycle	CTNNB1 CHMP2A CHMP2B	2.26e-03	164	33	3	GO:0007098
GeneOntologyBiologicalProcess	response to purine-containing compound	AKAP6 TAF1 RYR2	2.34e-03	166	33	3	GO:0014074
GeneOntologyBiologicalProcess	regulation of mesenchymal cell proliferation	CTNNB1 SYNE1	2.35e-03	45	33	2	GO:0010464
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	EVI5 PRKD1 STX1A CTNNB1 CHMP2A SYNE1 CHMP2B	2.37e-03	1189	33	7	GO:0044087
GeneOntologyCellularComponent	nuclear envelope	AKAP6 STX1A CTNNB1 CHMP2A SYNE1 RYR2 CHMP2B	1.79e-05	560	32	7	GO:0005635
GeneOntologyCellularComponent	membrane protein complex	AKAP6 EMC7 STX1A EVC2 CTNNB1 CHMP2A SYNE1 RYR2 CHMP2B SLC5A3	5.19e-05	1498	32	10	GO:0098796
GeneOntologyCellularComponent	autophagosome membrane	PRKD1 CHMP2A CHMP2B	9.01e-05	57	32	3	GO:0000421
GeneOntologyCellularComponent	junctional sarcoplasmic reticulum membrane	AKAP6 RYR2	1.01e-04	10	32	2	GO:0014701
GeneOntologyCellularComponent	amphisome membrane	CHMP2A CHMP2B	1.75e-04	13	32	2	GO:1904930
GeneOntologyCellularComponent	ESCRT III complex	CHMP2A CHMP2B	2.04e-04	14	32	2	GO:0000815
GeneOntologyCellularComponent	amphisome	CHMP2A CHMP2B	2.35e-04	15	32	2	GO:0044753
GeneOntologyCellularComponent	supramolecular fiber	PRKD1 KIF3C CTNNB1 CHMP2A SYNE1 RYR2 CHMP2B CEP57L1	3.12e-04	1179	32	8	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	PRKD1 KIF3C CTNNB1 CHMP2A SYNE1 RYR2 CHMP2B CEP57L1	3.27e-04	1187	32	8	GO:0099081
GeneOntologyCellularComponent	midbody	DTNBP1 CHMP2A SYNE1 CHMP2B	3.53e-04	222	32	4	GO:0030496
GeneOntologyCellularComponent	cation channel complex	AKAP6 STX1A RYR2 SLC5A3	4.37e-04	235	32	4	GO:0034703
GeneOntologyCellularComponent	kinetochore microtubule	CHMP2A CHMP2B	5.14e-04	22	32	2	GO:0005828
GeneOntologyCellularComponent	sarcomere	PRKD1 CTNNB1 SYNE1 RYR2	5.44e-04	249	32	4	GO:0030017
GeneOntologyCellularComponent	spindle	EVI5 CTNNB1 CHMP2A CDC16 CHMP2B	6.93e-04	471	32	5	GO:0005819
GeneOntologyCellularComponent	sarcoplasm	AKAP6 DTNBP1 RYR2	6.98e-04	114	32	3	GO:0016528
GeneOntologyCellularComponent	myofibril	PRKD1 CTNNB1 SYNE1 RYR2	7.67e-04	273	32	4	GO:0030016
GeneOntologyCellularComponent	autophagosome	PRKD1 CHMP2A CHMP2B	7.91e-04	119	32	3	GO:0005776
GeneOntologyCellularComponent	contractile muscle fiber	PRKD1 CTNNB1 SYNE1 RYR2	9.61e-04	290	32	4	GO:0043292
GeneOntologyCellularComponent	multivesicular body membrane	CHMP2A CHMP2B	9.61e-04	30	32	2	GO:0032585
GeneOntologyCellularComponent	ESCRT complex	CHMP2A CHMP2B	1.09e-03	32	32	2	GO:0036452
GeneOntologyCellularComponent	Z disc	PRKD1 CTNNB1 RYR2	1.57e-03	151	32	3	GO:0030018
GeneOntologyCellularComponent	Schaffer collateral - CA1 synapse	STX1A CTNNB1 DTNBP1	1.69e-03	155	32	3	GO:0098685
GeneOntologyCellularComponent	nuclear membrane	AKAP6 STX1A CTNNB1 SYNE1	1.90e-03	349	32	4	GO:0031965
GeneOntologyCellularComponent	I band	PRKD1 CTNNB1 RYR2	2.06e-03	166	32	3	GO:0031674
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	AKAP6 RYR2	2.16e-03	45	32	2	GO:0033017
GeneOntologyCellularComponent	monoatomic ion channel complex	AKAP6 STX1A RYR2 SLC5A3	2.54e-03	378	32	4	GO:0034702
GeneOntologyCellularComponent	sarcolemma	AKAP6 DTNBP1 RYR2	3.02e-03	190	32	3	GO:0042383
GeneOntologyCellularComponent	postsynaptic membrane	STX1A CTNNB1 DTNBP1 SYNE1	3.25e-03	405	32	4	GO:0045211
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	AKAP6 EMC7 FMO3 DTNBP1 NFE2L1 SYNE1 RYR2	3.38e-03	1327	32	7	GO:0042175
GeneOntologyCellularComponent	nuclear protein-containing complex	SMU1 TAF1 CTNNB1 CHMP2A SYNE1 CDC16 CHMP2B	4.15e-03	1377	32	7	GO:0140513
GeneOntologyCellularComponent	postsynaptic density	STX1A CTNNB1 DTNBP1 CHMP2B	4.77e-03	451	32	4	GO:0014069
GeneOntologyCellularComponent	intercalated disc	AKAP6 CTNNB1	4.86e-03	68	32	2	GO:0014704
GeneOntologyCellularComponent	organelle envelope	AKAP6 STX1A CTNNB1 CHMP2A SYNE1 RYR2 CHMP2B	5.21e-03	1435	32	7	GO:0031967
GeneOntologyCellularComponent	calcium channel complex	AKAP6 RYR2	5.58e-03	73	32	2	GO:0034704
GeneOntologyCellularComponent	asymmetric synapse	STX1A CTNNB1 DTNBP1 CHMP2B	5.80e-03	477	32	4	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	STX1A CTNNB1 DTNBP1 CHMP2B	6.98e-03	503	32	4	GO:0099572
GeneOntologyCellularComponent	spindle microtubule	CHMP2A CHMP2B	7.66e-03	86	32	2	GO:0005876
GeneOntologyCellularComponent	neuron to neuron synapse	STX1A CTNNB1 DTNBP1 CHMP2B	8.00e-03	523	32	4	GO:0098984
GeneOntologyCellularComponent	transmembrane transporter complex	AKAP6 STX1A RYR2 SLC5A3	8.00e-03	523	32	4	GO:1902495
GeneOntologyCellularComponent	sarcoplasmic reticulum	AKAP6 RYR2	8.01e-03	88	32	2	GO:0016529
GeneOntologyCellularComponent	multivesicular body	CHMP2A CHMP2B	8.01e-03	88	32	2	GO:0005771
GeneOntologyCellularComponent	microtubule	KIF3C CHMP2A CHMP2B CEP57L1	8.53e-03	533	32	4	GO:0005874
GeneOntologyCellularComponent	voltage-gated potassium channel complex	STX1A SLC5A3	8.54e-03	91	32	2	GO:0008076
GeneOntologyCellularComponent	cell-cell contact zone	AKAP6 CTNNB1	9.09e-03	94	32	2	GO:0044291
GeneOntologyCellularComponent	transporter complex	AKAP6 STX1A RYR2 SLC5A3	9.51e-03	550	32	4	GO:1990351
GeneOntologyCellularComponent	nuclear pore	CHMP2A CHMP2B	1.04e-02	101	32	2	GO:0005643
GeneOntologyCellularComponent	synaptic vesicle	STX1A KIF3C DTNBP1	1.07e-02	300	32	3	GO:0008021
GeneOntologyCellularComponent	potassium channel complex	STX1A SLC5A3	1.10e-02	104	32	2	GO:0034705
GeneOntologyCellularComponent	synaptic membrane	STX1A CTNNB1 DTNBP1 SYNE1	1.16e-02	583	32	4	GO:0097060
GeneOntologyCellularComponent	microtubule organizing center	TSGA10 EVI5 CTNNB1 CDC16 CEP57L1	1.22e-02	919	32	5	GO:0005815
GeneOntologyCellularComponent	neuron projection cytoplasm	KIF3C DTNBP1	1.23e-02	110	32	2	GO:0120111
GeneOntologyCellularComponent	caveola	AKAP6 CTNNB1	1.25e-02	111	32	2	GO:0005901
GeneOntologyCellularComponent	endoplasmic reticulum membrane	AKAP6 EMC7 FMO3 DTNBP1 NFE2L1 RYR2	1.25e-02	1293	32	6	GO:0005789
GeneOntologyCellularComponent	exocytic vesicle	STX1A KIF3C DTNBP1	1.27e-02	320	32	3	GO:0070382
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	AKAP6 EMC7 FMO3 DTNBP1 NFE2L1 RYR2	1.28e-02	1299	32	6	GO:0098827
GeneOntologyCellularComponent	endosome membrane	RHOBTB1 DTNBP1 CHMP2A CHMP2B	1.29e-02	602	32	4	GO:0010008
GeneOntologyCellularComponent	perinuclear region of cytoplasm	AKAP6 PRKD1 CTNNB1 SYNE1 SLC5A3	1.30e-02	934	32	5	GO:0048471
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	STX1A RHOBTB1 DTNBP1 CHMP2A NBEAL2 CHMP2B	1.32e-02	1307	32	6	GO:0030659
Domain	Snf7_fam	CHMP2A CHMP2B	1.98e-04	12	33	2	IPR005024
Domain	Snf7	CHMP2A CHMP2B	1.98e-04	12	33	2	PF03357
Domain	Spectrin/alpha-actinin	AKAP6 SYNE1	1.45e-03	32	33	2	IPR018159
Domain	SPEC	AKAP6 SYNE1	1.45e-03	32	33	2	SM00150
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	AKAP6 KIF3C DTNBP1 SYNE1 CEP57L1	3.63e-07	151	34	5	17043677
Pubmed	The ESCRT-III isoforms CHMP2A and CHMP2B display different effects on membranes upon polymerization.	CHMP2A CHMP2B	9.28e-07	2	34	2	33832485
Pubmed	Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers.	AKAP6 RYR2	9.28e-07	2	34	2	11352932
Pubmed	Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.	MCC CTNNB1	9.28e-07	2	34	2	18591935
Pubmed	Beta-catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1.	PRKD1 CTNNB1	2.78e-06	3	34	2	17979146
Pubmed	Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.	MCC CTNNB1	2.78e-06	3	34	2	27208794
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	RHOBTB1 SASH1 KLHL18 SYNE1	2.91e-06	101	34	4	9872452
Pubmed	ESCRT-III subunits Snf7-1 and Snf7-2 differentially regulate transmembrane cargos in hESC-derived human neurons.	CHMP2A CHMP2B	5.56e-06	4	34	2	21975012
Pubmed	ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding.	CHMP2A CHMP2B	5.56e-06	4	34	2	23051622
Pubmed	MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.	MCC CTNNB1	5.56e-06	4	34	2	24824780
Pubmed	Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy.	AKAP6 RYR2	1.39e-05	6	34	2	23540699
Pubmed	ESCRT-III recognition by VPS4 ATPases.	CHMP2A CHMP2B	1.39e-05	6	34	2	17928862
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	TSGA10 SYNE1 CDC16 RYR2	2.18e-05	168	34	4	30631154
Pubmed	Ab initio protein modelling reveals novel human MIT domains.	CHMP2A CHMP2B	2.59e-05	8	34	2	19302785
Pubmed	CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins.	CHMP2A CHMP2B	2.59e-05	8	34	2	11559748
Pubmed	Expression analysis of mouse Rhobtb3 using a LacZ reporter and preliminary characterization of a knockout strain.	CTNNB1 RHOBTB1	2.59e-05	8	34	2	24923387
Pubmed	ESCRT requirements for EIAV budding.	CHMP2A CHMP2B	2.59e-05	8	34	2	24107264
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SMU1 MCC NADK PRKD1 KIF3C CTNNB1 DTNBP1 CDC16	3.19e-05	1321	34	8	27173435
Pubmed	Comprehensive analysis of the human ESCRT-III-MIT domain interactome reveals new cofactors for cytokinetic abscission.	CHMP2A CHMP2B	5.07e-05	11	34	2	36107470
Pubmed	Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.	CHMP2A CHMP2B	5.07e-05	11	34	2	17984323
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	EVI5 CHMP2A CDC16 CHMP2B	5.20e-05	210	34	4	16565220
Pubmed	Structure of cellular ESCRT-III spirals and their relationship to HIV budding.	CHMP2A CHMP2B	6.08e-05	12	34	2	24878737
Pubmed	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	AKAP6 RYR2	6.08e-05	12	34	2	10830164
Pubmed	ESCRT machinery is required for plasma membrane repair.	CHMP2A CHMP2B	7.19e-05	13	34	2	24482116
Pubmed	The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor.	CHMP2A CHMP2B	7.19e-05	13	34	2	16554368
Pubmed	Secretory protein trafficking and organelle dynamics in living cells.	DTNBP1 CHMP2A CHMP2B	7.98e-05	85	34	3	11031247
Pubmed	ESCRT-III controls nuclear envelope reformation.	CHMP2A CHMP2B	8.38e-05	14	34	2	26040713
Pubmed	AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.	CHMP2A CHMP2B	9.66e-05	15	34	2	14505569
Pubmed	Membrane scission by the ESCRT-III complex.	CHMP2A CHMP2B	9.66e-05	15	34	2	19234443
Pubmed	Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing.	CHMP2A CHMP2B	9.66e-05	15	34	2	26040712
Pubmed	Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1.	CHMP2A CHMP2B	9.66e-05	15	34	2	16505166
Pubmed	Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.	CHMP2A CHMP2B	9.66e-05	15	34	2	20616062
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	AKAP6 TAF1 DTNBP1 NFE2L1 SYNE1	1.15e-04	497	34	5	23414517
Pubmed	The protein network of HIV budding.	CHMP2A CHMP2B	1.41e-04	18	34	2	14505570
Pubmed	The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth.	STX1A DTNBP1	1.41e-04	18	34	2	19546860
Pubmed	Progenitor death drives retinal dysplasia and neuronal degeneration in a mouse model of ATRIP-Seckel syndrome.	STX1A CTNNB1	1.41e-04	18	34	2	32994318
Pubmed	Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins.	CHMP2A CHMP2B	1.41e-04	18	34	2	14519844
Pubmed	Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development.	STX1A CTNNB1	2.12e-04	22	34	2	29249622
Pubmed	Function of atypical protein kinase C lambda in differentiating photoreceptors is required for proper lamination of mouse retina.	STX1A CTNNB1	2.32e-04	23	34	2	16267237
Pubmed	Loss of connectin novex-3 leads to heart dysfunction associated with impaired cardiomyocyte proliferation and abnormal nuclear mechanics.	SYNE1 RYR2	2.74e-04	25	34	2	38877142
Pubmed	Screening the proteins that interact with calpain in a human heart cDNA library using a yeast two-hybrid system.	NFE2L1 SYNE1	2.74e-04	25	34	2	12358155
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SAFB2 MCC PRKD1 CTNNB1 CABIN1 SYNE1	3.07e-04	963	34	6	28671696
Pubmed	Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.	DCAF15 KLHL18 CDC16	3.34e-04	138	34	3	28786561
Pubmed	Membrane budding and scission by the ESCRT machinery: it's all in the neck.	CHMP2A CHMP2B	3.70e-04	29	34	2	20588296
Pubmed	Redundant Roles of Rpn10 and Rpn13 in Recognition of Ubiquitinated Proteins and Cellular Homeostasis.	CTNNB1 NFE2L1	4.24e-04	31	34	2	26222436
Pubmed	ESCRT-dependent control of craniofacial morphogenesis with concomitant perturbation of NOTCH signaling.	CHMP2A CHMP2B	4.24e-04	31	34	2	37573008
Pubmed	Lynch Syndrome	MCC CTNNB1	4.81e-04	33	34	2	20301390
Pubmed	DNA Damage Regulates Translation through β-TRCP Targeting of CReP.	ZNF395 CTNNB1	5.41e-04	35	34	2	26091241
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AKAP6 SAFB2 NADK RHBDL2 NFE2L1 CEP57L1	5.76e-04	1084	34	6	11544199
Pubmed	Proteome-wide analysis of phospho-regulated PDZ domain interactions.	MCC EVI5	7.79e-04	42	34	2	30126976
Pubmed	Mapping the Genetic Landscape of Human Cells.	EMC7 TAF1 CHMP2A CDC16	9.51e-04	451	34	4	30033366
Interaction	AKAP6 interactions	AKAP6 DTNBP1 RYR2	2.68e-06	17	33	3	int:AKAP6
Interaction	DISC1 interactions	AKAP6 TSGA10 PRKD1 KIF3C SYNE1 CDC16 CEP57L1	4.99e-06	429	33	7	int:DISC1
Interaction	USP54 interactions	DCAF15 CTNNB1 CHMP2A CDC16 CHMP2B	2.29e-05	212	33	5	int:USP54
Interaction	COPS2 interactions	PRKD1 CTNNB1 RHOBTB1 KLHL18 CDC16	5.86e-05	258	33	5	int:COPS2
Interaction	ZNF490 interactions	TSGA10 STX1A DTNBP1	7.44e-05	50	33	3	int:ZNF490
Interaction	LAD1 interactions	PRKD1 CTNNB1 KLHL18	9.37e-05	54	33	3	int:LAD1
GeneFamily	Charged multivesicular body proteins\|ESCRT-III	CHMP2A CHMP2B	3.84e-05	7	25	2	1118
GeneFamily	Charged multivesicular body proteins\|ESCRT-III associated factors	CHMP2A CHMP2B	1.00e-04	11	25	2	482
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	RHOBTB1 KLHL18	1.46e-02	134	25	2	861
ToppCell	cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TSGA10 RHBDL2 FMO3	2.44e-04	160	34	3	9049707a4487f2337a17976ceb5fbd8815ab9e1d
ToppCell	cellseq2-Epithelial-Epithelial_Neuro-Secretory\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TSGA10 RHBDL2 FMO3	2.44e-04	160	34	3	0eb50b3c494e1b65d40104b3b5411b57bb72b959
ToppCell	cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TSGA10 RHBDL2 FMO3	2.44e-04	160	34	3	f2cfec54cf48a655f473b830be7d141c54b521ff
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SAFB2 MCC STX1A	2.76e-04	167	34	3	528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SAFB2 MCC STX1A	2.76e-04	167	34	3	a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCell	PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLHL18 SYNE1 NBEAL2	3.01e-04	172	34	3	c05af6e559f6af0fb15cefa03ffa1413e98a1a4a
ToppCell	PND10-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLHL18 SYNE1 NBEAL2	3.01e-04	172	34	3	953b05f776348cff784e79c93df65841939d880f
ToppCell	normal_Lung-T/NK_cells-Exhausted_Tfh\|normal_Lung / Location, Cell class and cell subclass	KIF3C RYR2 SLC5A3	3.06e-04	173	34	3	e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330
ToppCell	normal_Lung-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	KIF3C RYR2 SLC5A3	3.11e-04	174	34	3	e324320b52c904496e26fcecfa179b3431729ec0
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NADK FMO3 CCDC183	3.11e-04	174	34	3	3f0a5ce074675d57d479fa069385a1b3071e884e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 NBEAL2 SLC5A3	3.22e-04	176	34	3	5914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF3C RHOBTB1 SASH1	3.22e-04	176	34	3	88ca2f83d8301633232735f39b0683efe49d0b86
ToppCell	ASK452-Endothelial-Lymphatic\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	PRKD1 KIF3C KLHL18	3.22e-04	176	34	3	b4d280ecc07701d526f50d44c45ea91b3eeb00b1
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF3C RHOBTB1 SASH1	3.22e-04	176	34	3	7292e014b8f697f0c2e9f47c48333de95cb44a69
ToppCell	COVID-19-kidney-Stressed_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MCC CTNNB1 SASH1	3.38e-04	179	34	3	754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCell	Control-Classical_Monocyte-cMono_4\|Control / Disease condition and Cell class	STX1A CTNNB1 SLC5A3	3.50e-04	181	34	3	f3e1d8fe5cf1eba19e51c3680a55306cae687fe9
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 RHBDL2 RYR2	3.61e-04	183	34	3	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L1 RYR2 SLC5A3	3.79e-04	186	34	3	8eafd4bea692f7ef33de27dd53f9d1fe67deaad8
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	NADK CDC16 CEP57L1	3.79e-04	186	34	3	403ac98f72a42721f84fbd7826f251a88ae534a2
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRKD1 SASH1 SYNE1	3.79e-04	186	34	3	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AKAP6 SYNE1 RYR2	3.79e-04	186	34	3	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	AKAP6 PRKD1 RYR2	3.85e-04	187	34	3	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	MCC SASH1 SYNE1	3.91e-04	188	34	3	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	AKAP6 PRKD1 RYR2	3.91e-04	188	34	3	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	facs-Skin-nan-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC RHOBTB1 SYNE1	3.97e-04	189	34	3	6c71e81373cb7822de23c193a6350b6df9f567bc
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MCC SASH1 SYNE1	3.97e-04	189	34	3	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MCC SASH1 SYNE1	4.03e-04	190	34	3	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MCC SASH1 SYNE1	4.03e-04	190	34	3	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MCC SASH1 SYNE1	4.09e-04	191	34	3	f229abf69a1217194f74b0502486907e07dba989
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MCC RHOBTB1 SASH1	4.22e-04	193	34	3	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	AKAP6 TSGA10 SYNE1	4.22e-04	193	34	3	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	PRKD1 FMO3 RYR2	4.22e-04	193	34	3	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	MCC PRKD1 EVC2	4.22e-04	193	34	3	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	(06)_Krt4/13+-(2)_48hpi\|(06)_Krt4/13+ / shred by cell type and Timepoint	RHOBTB1 CHMP2B	4.25e-04	40	34	2	1e42cd186ee06ac9345e16ede649a72c15bdf2f8
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP6 TSGA10 SYNE1	4.28e-04	194	34	3	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRKD1 SYNE1 RYR2	4.28e-04	194	34	3	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	PRKD1 FMO3 RYR2	4.35e-04	195	34	3	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	5'-Adult-Appendix\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FMO3 SASH1 SYNE1	4.41e-04	196	34	3	a579211ef14f348d0c5a290553150222dfbf1515
ToppCell	droplet-Kidney-nan-3m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTNNB1 NFE2L1 SLC5A3	4.41e-04	196	34	3	b880c9665d42c76ea1971d4e49d7ecf72fcfafb6
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	MCC SASH1 SYNE1	4.41e-04	196	34	3	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 NFE2L1 RYR2	4.48e-04	197	34	3	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP6 TSGA10 SYNE1	4.48e-04	197	34	3	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	distal-Epithelial-Ionocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRKD1 STX1A RHBDL2	4.48e-04	197	34	3	11a5d2db2561d045756980ead61e1211c7dda100
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 SYNE1 RYR2	4.48e-04	197	34	3	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	distal-Epithelial-Ionocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRKD1 STX1A RHBDL2	4.48e-04	197	34	3	7a2cd970fe0866057999e40d15367b2b3324ae59
ToppCell	3'-Adult-Distal_Rectal-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RHBDL2 CTNNB1 SLC5A3	4.54e-04	198	34	3	ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 RHBDL2 RYR2	4.54e-04	198	34	3	f261a37dd07976548b897af86df1d1a0dc069889
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 SYNE1 RYR2	4.54e-04	198	34	3	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	3'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RHBDL2 CTNNB1 SLC5A3	4.54e-04	198	34	3	7ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RHBDL2 CTNNB1 SLC5A3	4.54e-04	198	34	3	1fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 SYNE1 RYR2	4.54e-04	198	34	3	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RHBDL2 CTNNB1 SLC5A3	4.54e-04	198	34	3	4f26a60e99f42343e5af7221723e108a1a1b7827
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF3C SASH1 SYNE1	4.54e-04	198	34	3	99d6a64f3410dae3019161feef20a8f06081a24b
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	PRKD1 SASH1 SYNE1	4.68e-04	200	34	3	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	PRKD1 SASH1 SYNE1	4.68e-04	200	34	3	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3\|Control_saline / Treatment groups by lineage, cell group, cell type	AKAP6 SYNE1 RYR2	4.68e-04	200	34	3	b0866b497aa71d06cef25f9a335fa584e95fa7e0
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	AKAP6 SYNE1 RYR2	4.68e-04	200	34	3	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	AKAP6 SYNE1 RYR2	4.68e-04	200	34	3	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	AKAP6 SYNE1 RYR2	4.68e-04	200	34	3	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	PRKD1 SASH1 SYNE1	4.68e-04	200	34	3	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	AKAP6 SYNE1 RYR2	4.68e-04	200	34	3	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	PRKD1 SASH1 SYNE1	4.68e-04	200	34	3	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	PRKD1 SASH1 SYNE1	4.68e-04	200	34	3	7136936d05ab344a560cf159684c881063b5430d
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	PRKD1 SASH1 SYNE1	4.68e-04	200	34	3	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	AKAP6 SYNE1 RYR2	4.68e-04	200	34	3	7c62678cf408aaaf98d6df0fb27814d2007c4521
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	TSGA10 SAFB2 EVI5 DCAF15 KIF3C CABIN1 RYR2	1.16e-08	191	34	7	4969_DN
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	SAFB2 MCC NADK KIF3C SASH1 CABIN1	4.27e-07	197	34	6	3195_DN
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; HL60; HG-U133A	AKAP6 NADK EVI5 NFE2L1 KLHL18 NBEAL2	4.53e-07	199	34	6	1386_UP
Drug	AC1ND2OB	SAFB2 PRKD1 TAF1 FMO3 CTNNB1 CHMP2A	2.40e-06	265	34	6	CID004568637
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	NADK DCAF15 STX1A CABIN1 NBEAL2	9.23e-06	192	34	5	4330_DN
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	TSGA10 MCC STX1A TAF1 SASH1	9.47e-06	193	34	5	5024_DN
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	STX1A TAF1 CABIN1 NBEAL2 RYR2	9.95e-06	195	34	5	3525_DN
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	EVI5 STX1A KIF3C TAF1 SASH1	1.05e-05	197	34	5	3186_DN
Drug	Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; PC3; HT_HG-U133A	EVI5 KIF3C TAF1 SASH1 NBEAL2	1.05e-05	197	34	5	7273_DN
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	SAFB2 DCAF15 ZNF395 SASH1 CABIN1	1.07e-05	198	34	5	2847_DN
Drug	triphenylethylene	SAFB2 PRKD1 TAF1	4.42e-05	46	34	3	CID000006025
Drug	N-desmethyl-tamoxifen-hydrochloride	SAFB2 PRKD1 FMO3	6.40e-05	52	34	3	CID000035887
Drug	lithium chromate	PRKD1 CTNNB1 DTNBP1 CHMP2A SYNE1	7.33e-05	296	34	5	CID000026627
Drug	lithium aluminum hydride	PRKD1 CTNNB1 CABIN1 CHMP2A SYNE1	1.06e-04	320	34	5	CID000028112
Drug	4-nonylphenol	SAFB2 PRKD1 CABIN1	1.19e-04	64	34	3	CID000001752
Drug	2-phenylindole	SAFB2 TAF1	1.67e-04	13	34	2	CID000013698
Drug	oxazolidine	TAF1 SYNE1	1.67e-04	13	34	2	CID000536683
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	SAFB2 MCC DCAF15 SLC5A3	1.76e-04	189	34	4	6717_DN
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A	MCC DCAF15 TAF1 SLC5A3	1.79e-04	190	34	4	6718_DN
Drug	Niclosamide [50-65-7]; Down 200; 12.2uM; PC3; HT_HG-U133A	SAFB2 DCAF15 TAF1 RYR2	1.86e-04	192	34	4	4018_DN
Drug	Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; PC3; HT_HG-U133A	MCC EVI5 KIF3C RHOBTB1	1.90e-04	193	34	4	4671_DN
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	NADK DCAF15 KLHL18 SLC5A3	1.90e-04	193	34	4	4343_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A	TSGA10 MCC STX1A TAF1	1.94e-04	194	34	4	3321_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	SAFB2 DCAF15 CABIN1 NBEAL2	1.94e-04	194	34	4	7446_DN
Drug	Althiazide [5588-16-9]; Down 200; 10.4uM; HL60; HT_HG-U133A	NADK EVI5 DCAF15 CDC16	1.94e-04	194	34	4	2527_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	NADK EVI5 RHOBTB1 CDC16	1.94e-04	194	34	4	2504_DN
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A	KIF3C TAF1 SASH1 CABIN1	1.98e-04	195	34	4	5455_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A	NADK EVI5 NBEAL2 RYR2	1.98e-04	195	34	4	5618_DN
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A	TSGA10 NADK DCAF15 CABIN1	2.02e-04	196	34	4	4779_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A	SAFB2 DCAF15 TAF1 NBEAL2	2.02e-04	196	34	4	7027_DN
Drug	Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	SAFB2 MCC DCAF15 CABIN1	2.02e-04	196	34	4	5081_DN
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	NADK KIF3C TAF1 SASH1	2.02e-04	196	34	4	6898_DN
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	DCAF15 SASH1 CABIN1 RYR2	2.02e-04	196	34	4	5528_DN
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A	TSGA10 SAFB2 EVI5 DCAF15	2.02e-04	196	34	4	4984_DN
Drug	Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	TSGA10 SAFB2 NADK TAF1	2.02e-04	196	34	4	6229_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A	SAFB2 NADK STX1A TAF1	2.02e-04	196	34	4	3277_UP
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A	EVI5 STX1A KIF3C SYNE1	2.06e-04	197	34	4	4767_DN
Drug	Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A	SAFB2 NADK EVI5 TAF1	2.06e-04	197	34	4	5349_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A	EVI5 STX1A KIF3C RYR2	2.06e-04	197	34	4	2554_DN
Drug	Phenindione [83-12-5]; Up 200; 18uM; HL60; HG-U133A	MCC EVI5 DCAF15 KLHL18	2.06e-04	197	34	4	1718_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SAFB2 MCC CABIN1 RYR2	2.06e-04	197	34	4	7425_DN
Drug	Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SAFB2 NADK EVI5 STX1A	2.06e-04	197	34	4	2765_DN
Drug	E)-4-hydroxytamoxifen	SAFB2 PRKD1 TAF1 CHMP2A	2.06e-04	197	34	4	CID000063062
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	KIF3C SASH1 CABIN1 NBEAL2	2.06e-04	197	34	4	6218_DN
Drug	Ajmaline [4360-12-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SAFB2 NADK STX1A TAF1	2.06e-04	197	34	4	2899_DN
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A	MCC NADK TAF1 NBEAL2	2.06e-04	197	34	4	1796_UP
Drug	Sulmazole [73384-60-8]; Down 200; 14uM; PC3; HT_HG-U133A	SAFB2 DCAF15 CABIN1 SYNE1	2.06e-04	197	34	4	4009_DN
Drug	Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A	NADK EVI5 DCAF15 TAF1	2.06e-04	197	34	4	6758_DN
Drug	Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A	SAFB2 EVI5 TAF1 RYR2	2.06e-04	197	34	4	3242_UP
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	SAFB2 NADK SYNE1 RYR2	2.06e-04	197	34	4	2822_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	TSGA10 SAFB2 EVI5 SYNE1	2.06e-04	197	34	4	4764_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SAFB2 STX1A TAF1 CABIN1	2.06e-04	197	34	4	7038_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	SAFB2 MCC KIF3C SASH1	2.06e-04	197	34	4	6456_DN
Drug	Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A	SAFB2 NADK DCAF15 SASH1	2.06e-04	197	34	4	7472_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HT_HG-U133A	MCC EVI5 DCAF15 RYR2	2.10e-04	198	34	4	3990_DN
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	MCC NADK KIF3C CABIN1	2.10e-04	198	34	4	1798_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; HL60; HG-U133A	MCC DCAF15 KLHL18 NBEAL2	2.10e-04	198	34	4	1431_UP
Drug	Zidovudine, AZT [30516-87-1]; Up 200; 15uM; HL60; HG-U133A	NADK EVI5 DCAF15 SASH1	2.10e-04	198	34	4	1595_UP
Drug	Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A	MCC NADK CABIN1 SLC5A3	2.10e-04	198	34	4	3898_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; HL60; HT_HG-U133A	SAFB2 MCC EVI5 STX1A	2.10e-04	198	34	4	2458_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; HL60; HG-U133A	AKAP6 MCC NADK KLHL18	2.10e-04	198	34	4	1748_UP
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A	SAFB2 EVI5 DCAF15 RYR2	2.10e-04	198	34	4	5405_DN
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A	SAFB2 NADK EVI5 KIF3C	2.10e-04	198	34	4	7327_UP
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	SAFB2 MCC STX1A TAF1	2.10e-04	198	34	4	3542_DN
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A	MCC DCAF15 KIF3C CABIN1	2.10e-04	198	34	4	6603_DN
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A	MCC PRKD1 CABIN1 SYNE1	2.10e-04	198	34	4	6668_DN
Drug	Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	NADK RHOBTB1 CABIN1 NBEAL2	2.10e-04	198	34	4	6271_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A	NADK KIF3C TAF1 RYR2	2.10e-04	198	34	4	5433_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	DCAF15 CABIN1 SYNE1 RYR2	2.10e-04	198	34	4	4005_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A	STX1A KIF3C SASH1 RYR2	2.10e-04	198	34	4	5885_DN
Drug	Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	SAFB2 MCC NADK RYR2	2.10e-04	198	34	4	3231_DN
Drug	Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A	AKAP6 TSGA10 SAFB2 SASH1	2.10e-04	198	34	4	6206_UP
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	SAFB2 DCAF15 SASH1 NBEAL2	2.14e-04	199	34	4	4831_DN
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A	DCAF15 STX1A SASH1 SYNE1	2.14e-04	199	34	4	2819_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SAFB2 NADK SASH1 CABIN1	2.14e-04	199	34	4	7433_DN
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	NADK DCAF15 CABIN1 RYR2	2.14e-04	199	34	4	4294_DN
Drug	Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	SAFB2 KIF3C NBEAL2 RYR2	2.14e-04	199	34	4	3223_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	SAFB2 EVI5 STX1A CABIN1	2.14e-04	199	34	4	4691_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	SAFB2 KIF3C SASH1 CABIN1	2.14e-04	199	34	4	7000_DN
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; PC3; HT_HG-U133A	SAFB2 NADK SASH1 NBEAL2	2.14e-04	199	34	4	7279_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; HL60; HG-U133A	MCC NADK DCAF15 KIF3C	2.14e-04	199	34	4	1768_UP
Drug	4-hydroxytestosterone	SAFB2 CTNNB1 CHMP2A	2.14e-04	78	34	3	CID000160615
Drug	Pheniramine maleate [132-20-7]; Up 200; 11.2uM; MCF7; HT_HG-U133A	TSGA10 STX1A CABIN1 SLC5A3	2.18e-04	200	34	4	1492_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; HL60; HT_HG-U133A	SAFB2 STX1A KIF3C RHOBTB1	2.18e-04	200	34	4	2453_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; HL60; HT_HG-U133A	KIF3C RHOBTB1 KLHL18 CHMP2B	2.18e-04	200	34	4	1846_UP
Drug	cannon	DTNBP1 CHMP2A CHMP2B	2.67e-04	84	34	3	CID003050747
Drug	3-(1H-pyrrole-2-carboxylate	AKAP6 PRKD1 CABIN1 RYR2	3.89e-04	233	34	4	CID000005114
Drug	BT-B	TSGA10 PRKD1 CTNNB1 RHOBTB1	4.56e-04	243	34	4	CID000081462
Disease	urate measurement, bone density	AKAP6 MCC RHOBTB1 DTNBP1 CABIN1 SYNE1	4.74e-05	619	32	6	EFO_0003923, EFO_0004531
Disease	Colorectal Carcinoma	AKAP6 MCC PRKD1 EVC2 CTNNB1 SYNE1	9.49e-05	702	32	6	C0009402
Disease	Polyposis, Adenomatous Intestinal	MCC FMO3	1.35e-04	16	32	2	C2713442
Disease	Familial Intestinal Polyposis	MCC FMO3	1.35e-04	16	32	2	C2713443
Disease	Adenomatous Polyposis Coli	MCC FMO3	1.53e-04	17	32	2	C0032580
Disease	Adenocarcinoma of large intestine	MCC TAF1 CTNNB1	1.55e-04	96	32	3	C1319315
Disease	Colorectal cancer	MCC CTNNB1	3.93e-04	27	32	2	cv:C0346629
Disease	COLORECTAL CANCER	MCC CTNNB1	3.93e-04	27	32	2	114500
Disease	Neoplasm of the large intestine	MCC CTNNB1	3.93e-04	27	32	2	cv:C0009404
Disease	Myopia	AKAP6 STX1A CTNNB1 RYR2	7.69e-04	385	32	4	HP_0000545
Disease	Salivary Gland Neoplasms	PRKD1 CTNNB1	1.19e-03	47	32	2	C0036095
Disease	Intellectual Disability	AKAP6 MCC TAF1 SYNE1	1.34e-03	447	32	4	C3714756
Disease	Metastatic melanoma	PRKD1 TAF1	1.57e-03	54	32	2	C0278883

Protein segments in the cluster

Peptide	Gene	Start	Entry
HMAANMLNKEMMETL	ANKRD61	206	A6NGH8
RQAEIMDMKEEMMND	CHMP2A	131	O43633
MDMKEEMMNDAIDDA	CHMP2A	136	O43633
ENMKMEMTEEMINDT	CHMP2B	131	Q9UQN3
DLMSIMEMQAMEVNT	NFE2L1	316	Q14494
MATQADLMELDMAME	CTNNB1	1	P35222
LMDDMEEAMVQDAEM	PRKD1	356	Q15139
SMEDMMNDINEKMEK	FMO3	401	P31513
MQQEMMLRDEETMEL	KIF3C	556	O14782
MEMEQEKMTMNKELS	NADK	1	O95544
QMNQAELMQLDMEGM	EVI5	361	O60447
MEVNVDMLEQMDLMD	DTNBP1	231	Q96EV8
MENQYQREMMAMEEA	EVC2	466	Q86UK5
EIEMNESDMMLETSM	CDC16	601	Q13042
LDLENAVLMQELMAM	MCC	611	P23508
AVLMQELMAMKEEMA	MCC	616	P23508
MMECKQDEIVMQGMD	KLHL18	71	O94889
MMLMSLSCMELQLDQ	CABIN1	541	Q9Y6J0
DMKIMSQDAMMITDE	CCDC183	206	Q5T5S1
LLMAMQDELDQMSME	CEP57L1	326	Q8IYX8
SDPDMRREMEQSMNM	EMC7	186	Q9NPA0
LMDLQKDMVVMLLSM	RYR2	3971	Q92736
LMNMMMMSDENHRDI	DCAF15	166	Q66K64
DLEMESMNLNMGREM	RHBDL2	6	Q9NX52
PMDMEAQLMDCQNML	SYNE1	6116	Q8NF91
QENTRMDMENEESMM	TAF1	1766	P21675
AMDMNVLMSAQLLME	NBEAL2	991	Q6ZNJ1
LMMAVMIAALMSDLD	SLC5A3	366	P53794
EMFDLRMMVENIMNK	RHOBTB1	441	O94844
IDMESLVMDSHDLMM	AKAP6	976	Q13023
AQDNFMMMDDAVLCM	SMU1	256	Q2TAY7
ELHDMFMDMAMLVES	STX1A	211	Q16623
FMDMAMLVESQGEMI	STX1A	216	Q16623
DAVEMDEMMAAMVLT	ZNF395	161	Q9H8N7
EITMSDEERIQLMMM	SASH1	181	O94885
MEASLENLQNMGMMD	SAFB2	116	Q14151
ENLQNMGMMDMSVLD	SAFB2	121	Q14151
MGMMDMSVLDETEVA	SAFB2	126	Q14151
DERMEQMSNMTLMKE	TSGA10	156	Q9BZW7